Check Eligibility Health History Review of medical conditions, medications, allergies, blood sugar history, prior weight loss attempts, and weight-related concerns
Chemical Name: Retatrutide (LY3437943) Classification: Triple hormone receptor agonist Mechanism: GLP-1/GIP/Glucagon receptor agonist Research Applications: Metabolic pathway research Glucose regulation mechanism studies Energy expenditure analysis Lipid metabolism research Incretin hormone pathway investigation Hepatic fat reduction studies Multi-receptor agonism research Product Specifications: Form: Lyophilized powder Purity: High purity research grade Storage: Store at -20C, protect from light and moisture Reconstitution: Use bacteriostatic water (not included) Stability: 24 months when stored properly, 30 days once reconstituted Research Background: Retatrutide is an investigational triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors
Third-party tested GHK-cu (50mg)
Krogh ultimately founded the company that became Novo Nordisk, which today manufactures about half of the worlds supply of insulin
Cell protection: It helps neutralize free radicals, thus reducing oxidative stress and protecting cells from damage
